Effects of High Dose Opioids and Sedatives on Survival in Terminally Ill Cancer Patients
- 1 April 2001
- journal article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 21 (4) , 282-289
- https://doi.org/10.1016/s0885-3924(01)00258-5
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- A comparison of the use of sedatives in a hospital support team and in a hospicePalliative Medicine, 1997
- Long-Term Subcutaneous Infusion of Midazolam for Refractory Delirium in Terminal Breast CancerSouthern Medical Journal, 1996
- Usage of haloperidol for delirium in cancer patientsSupportive Care in Cancer, 1996
- Sedation for symptom control in Japan: The importance of intermittent use and communication with family membersJournal of Pain and Symptom Management, 1996
- The use of propofol in palliative medicineJournal of Pain and Symptom Management, 1995
- Propofol in terminal careJournal of Pain and Symptom Management, 1995
- The use of chlorpromazine for symptom control in dying cancer patientsJournal of Pain and Symptom Management, 1994
- Titrated Intravenous Barbiturates in the Control of Symptoms in Patients With Terminal CancerSouthern Medical Journal, 1991
- Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of lifeJournal of Pain and Symptom Management, 1990
- Midazolam A Review of its Pharmacological Properties and Therapeutic UseDrugs, 1984